Proprietary AI analyst is now available
- Public Comps
- Kestra Medical Technologies
Kestra Medical Technologies Valuation Multiples
Discover revenue and EBITDA valuation multiples for Kestra Medical Technologies and similar public comparables like Sopharma, Shinva, BioLife Solutions, Gerresheimer and more.
Kestra Medical Technologies Overview
About Kestra Medical Technologies
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
Founded
2021
HQ

Employees
330
Website
Sectors
Financials (LTM)
EV
$949M
Valuation Multiples
Start free trialKestra Medical Technologies Financials
Kestra Medical Technologies reported last 12-month revenue of $97M and negative EBITDA of ($83M).
In the same LTM period, Kestra Medical Technologies generated $50M in gross profit, ($83M) in EBITDA losses, and had net loss of ($126M).
Revenue (LTM)
Kestra Medical Technologies P&L
In the most recent fiscal year, Kestra Medical Technologies reported revenue of $60M and EBITDA of ($80M).
Kestra Medical Technologies is unprofitable as of last fiscal year, with gross margin of 40%, EBITDA margin of (133%), and net margin of (190%).
Financial data powered by Morningstar, Inc.
Kestra Medical Technologies Stock Performance
Kestra Medical Technologies has current market cap of $1B, and enterprise value of $949M.
Market Cap Evolution
Kestra Medical Technologies' stock price is $20.45.
Kestra Medical Technologies share price decreased by 3.8% in the last 30 days, and increased by 23.3% in the last year.
Kestra Medical Technologies has an EPS (earnings per share) of $-1.95.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $949M | $1B | 8.4% | -3.8% | 2.6% | 23.3% | $-1.95 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialKestra Medical Technologies Valuation Multiples
Kestra Medical Technologies trades at 9.8x EV/Revenue multiple, and (11.5x) EV/EBITDA.
EV / Revenue (LTM)
Kestra Medical Technologies Financial Valuation Multiples
As of June 5, 2026, Kestra Medical Technologies has market cap of $1B and EV of $949M.
Kestra Medical Technologies has a P/E ratio of (9.5x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Kestra Medical Technologies Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Kestra Medical Technologies Margins & Growth Rates
Kestra Medical Technologies grew revenue by 55% and EBITDA by 5% in the last fiscal year.
In the most recent fiscal year, Kestra Medical Technologies reported gross margin of 40%, EBITDA margin of (133%), and net margin of (190%).
Kestra Medical Technologies Margins
Kestra Medical Technologies Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Kestra Medical Technologies Operational KPIs
Kestra Medical Technologies' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.4M for the same period.
Kestra Medical Technologies' Rule of 40 is (35%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Kestra Medical Technologies' Rule of X is 48% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Kestra Medical Technologies Competitors
Kestra Medical Technologies competitors include Sopharma, Shinva, BioLife Solutions, Gerresheimer, Paul Hartmann, Menicon, Chengzhi, Arjo, Inner Mongolia Furui Medical Science and Salus.
Most Kestra Medical Technologies public comparables operate across Medical Supplies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.0x | - | 9.8x | - | |||
| 0.6x | 0.6x | 6.7x | 6.7x | |||
| 13.1x | 12.1x | 50.7x | 46.5x | |||
| 1.4x | 1.2x | 7.1x | 7.1x | |||
| 0.4x | - | 4.0x | - | |||
| 1.3x | 1.2x | 8.7x | 7.4x | |||
| 1.3x | - | 15.4x | - | |||
| 0.6x | 0.6x | 3.6x | 3.6x | |||
This data is available for Pro users. Sign up to see all Kestra Medical Technologies competitors and their valuation data. Start Free Trial | ||||||
Kestra Medical Technologies VC Funding History
Before going public, Kestra Medical Technologies raised $196M in total equity funding, across 1 round.
Kestra Medical Technologies Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Kestra Medical Technologies
| When was Kestra Medical Technologies founded? | Kestra Medical Technologies was founded in 2021. |
| Where is Kestra Medical Technologies headquartered? | Kestra Medical Technologies is headquartered in United States. |
| How many employees does Kestra Medical Technologies have? | As of today, Kestra Medical Technologies has over 330 employees. |
| Who is the CEO of Kestra Medical Technologies? | Kestra Medical Technologies' CEO is Brian Webster. |
| Is Kestra Medical Technologies publicly listed? | Yes, Kestra Medical Technologies is a public company listed on Nasdaq. |
| What is the stock symbol of Kestra Medical Technologies? | Kestra Medical Technologies trades under KMTS ticker. |
| When did Kestra Medical Technologies go public? | Kestra Medical Technologies went public in 2025. |
| Who are competitors of Kestra Medical Technologies? | Kestra Medical Technologies main competitors include Sopharma, Shinva, BioLife Solutions, Gerresheimer, Paul Hartmann, Menicon, Chengzhi, Arjo, Inner Mongolia Furui Medical Science, Salus. |
| What is the current market cap of Kestra Medical Technologies? | Kestra Medical Technologies' current market cap is $1B. |
| What is the current revenue of Kestra Medical Technologies? | Kestra Medical Technologies' last 12 months revenue is $97M. |
| What is the current revenue growth of Kestra Medical Technologies? | Kestra Medical Technologies revenue growth (NTM/LTM) is 43%. |
| What is the current EV/Revenue multiple of Kestra Medical Technologies? | Current revenue multiple of Kestra Medical Technologies is 9.8x. |
| Is Kestra Medical Technologies profitable? | No, Kestra Medical Technologies is not profitable. |
| What is the current EBITDA of Kestra Medical Technologies? | Kestra Medical Technologies has negative EBITDA and is not profitable. |
| What is Kestra Medical Technologies' EBITDA margin? | Kestra Medical Technologies' last 12 months EBITDA margin is (85%). |
| What is the current EV/EBITDA multiple of Kestra Medical Technologies? | Current EBITDA multiple of Kestra Medical Technologies is (11.5x). |
| What is the current FCF of Kestra Medical Technologies? | Kestra Medical Technologies' last 12 months FCF is ($120M). |
| What is Kestra Medical Technologies' FCF margin? | Kestra Medical Technologies' last 12 months FCF margin is (124%). |
| What is the current EV/FCF multiple of Kestra Medical Technologies? | Current FCF multiple of Kestra Medical Technologies is (7.9x). |
| How many companies Kestra Medical Technologies has acquired to date? | Kestra Medical Technologies hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Kestra Medical Technologies has invested to date? | Kestra Medical Technologies hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Kestra Medical Technologies
Lists including Kestra Medical Technologies
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.